Aortech Share Discussion Threads

[landy90] 21/5/2018 08:50

Ely is a heart valve rock star, Berg a legend and checking out David Richmond, he is a medical textiles manufacturing expert, his team was responsible for the Lombard Medical endo vascular graft that they took from prototype design to a professionally manufactured product. That should be positive for the patches and grafts. The VFT team are highly rated internationally as experts in CFD and other computational modelling required for the heart valve. And they have regulatory assistance from Compliance Solutions. John McKenna is Europes best cardiovascular marketing man. All elements of the team are in place to make all the products a success.

[bearfoot] 21/5/2018 08:46

Great post! Thanks. As I feared, though. I am a non-trivial existing holder and selling and (hoping to) 'buy back' my stake in a minimal 500k open offer is a pipe-dream. How did you get in on the placing?

[k1ngkonggb] 21/5/2018 08:44

This has to be the biggest no brainer share. I think Stig's valuation of £100 could be quite conservative in a couple of years.

[turbotrader2] 21/5/2018 08:42

Like stig says Ely will see this at huge multiples

[the stigologist] 21/5/2018 08:33

Not sure why the price went anywhere near 30p. The Theoretical Ex Rights Price should be c.37p ? I'd do the calculation if I could be bothered. Some analyst probably already has.

[nextlink] 21/5/2018 08:30

After the placing well funded and likely to increase in value at a steady rate.
If you were a predator you would conclude, better to strike now rather than wait.
Danger if you sit on the sidelines to long you could miss a takeover.

[the stigologist] 21/5/2018 08:28

My cardiac specialist mate got back to me :

"Berg is a legend"

[joeblogg2] 21/5/2018 08:28

Yes great news on both product and new appointments!!!

[spawny100] 21/5/2018 08:27

The proof of the pudding is would you buy shares right now if not already locked in? I agree the new appointment shows some vision and potential but I'm in no hurry to buy back the shares I sold mid 40's at the mo as transformation will take time imo

[bones] 21/5/2018 08:25

Agree Stig.The lack of trading action this morning suggests this is SO UNDER THE RADAR. I'm just going to sit back here and watch the tide come in.

[the stigologist] 21/5/2018 08:20

That John Ely guy will sell this Company to Institutional Investors on his own frankly.

An ex FDA insider (so he'll know exactly how to navigate their processes, obviously some of his former mates would have to recuse themselves from considering his applications)

But the big multi-billion dollar MedTech background also provides a route to sale/route to market/Route to Partner as we proceed along the R&D process.

wow this is mega exciting!

seeing as start-up/VC companies like Harpoon/Xeltis go for $100-200m odd in this market and we've got £60m of 'invested capital' into the IP...

this could get very exciting very quickly (depending on how quickly the market wakes up to it anyway)

[the stigologist] 21/5/2018 08:16

John Ely (NED - Heart Valve Expert)

John is a recognised expert in cardiovascular devices and spent 7 years at the FDA, where he was responsible for a team that approved cardiovascular medical devices, including heart valves. In industry, he has successfully managed the process of obtaining pre-market approvals for 6 heart valves, including both tissue and mechanical valves. He has also led research and development, regulatory and quality assurance teams at Baxter International Inc., Edwards Lifesciences Corporation and On-X Life Technologies, Inc. He has authored over 25 scientific papers and is the named inventor on 3 US patents. He was previously engaged by AorTech as an expert witness in the area of heart valve design and development process, giving him an intimate knowledge of AorTech's heart valve project.

Geoffrey Berg (NED - Cardiovascular Expert)

Geoffrey was formerly a consultant heart surgeon at the Golden Jubilee Hospital in Glasgow where he specialised in surgical treatment of valvular heart disease and was recognised as one of the leading surgeons in mitral valve repair and replacement. He has authored a number of scientific papers on the treatment of heart disease and conducted studies into the long term performance of replacement heart valves. He has been involved in the early stage development of a number of cardiovascular devices, including a stentless animal tissue heart valve, and the launch of the only biological valved conduit. He is a recognised authority on stentless aortic valve surgery and has co-authored papers on stentless versus stented aortic valve insertions.

[mikeh30] 21/5/2018 08:15

Can't buy any. Blue finish hahhahaa

[timbo003] 21/5/2018 08:14

>>>Bearfoot

Yes, You are (partly) correct (I think)

* If you are a holder of shares purchased in the secondhand market and you hold those shares when the new shares are issued you will not qualify

* If you are a holder of shares purchased in the secondhand market and you sell those shares before the new shares are issued you should qualify

* If you are a holder of shares purchased as EIS shares and you hold those shares when the new shares are issued you will qualify


These placing shares will be my maiden purchase, so I should qualify regardless.


For existing shareholders who own second hand shares wishing to participate in the open offer and qualify for EIS tax breaks, it is difficult (but not impossible). The only way to do it, is to sell your existing shares before June 11th and apply for a sizable excess in the open offer.

[turbotrader2] 21/5/2018 08:14

This could finish flat

[parsons4] 21/5/2018 08:12

Yes no stock around just tried to top up !!! The game here is to go for some extra in the open offer !!!

[bones] 21/5/2018 08:12

The beast has woken up finally!Good that the open offer is only for those with shares held on Friday so no late ship jumpers! Reward for the longer term supporters when business looked a bit dormant.Once the small cap investing world sees that the enlarged company will still be worth only £5m with so much potential in its area of expertise (IP already long established), this should gain new interest.

[bearfoot] 21/5/2018 07:57

Timbo003, My understanding of the HMRC rules is that the placing and open offer shares are only EIS-qualifying if you do NOT currently own (or have previously owned) shares in the company. Are you a brand new holder? Or, maybe I have this wrong?

[turbotrader2] 21/5/2018 07:49

Timber is what's happening Why place at 30% discount if that good

[mikeh30] 21/5/2018 07:45

Managed to read the full announcement. Certainly a move forward with some super additions to the board.Let's see what happens today

[timbo003] 21/5/2018 07:40

I was fortunate enough to pick up a few in the placing. The placing and open offer shares are EIS/VCT qualifying, so net price is only 21p/share for qualifying shareholders, therefore these will be a three year hold (minimum) for me.

[the stigologist] 21/5/2018 07:39

I concur. Will ask my cardiac specialist mate who consults for many of the big medical device companies to give the bios a once over but all look pukka

If they have right Institutions behind the placing there won't be much loose stock around. We've basically had months to acquire stock in what is in effect a pre-IPO round and now it's about to become a proper listed company again so you should get a big private to public arena premia.

[landy90] 21/5/2018 07:28

In this sector, it is the device manufacturers who make the big margins. Aortech is going up the value chain but with devices that can be developed in the short term. The quality of the new partners is first class and the additions to the Board world class. Look at John Ely- he ran the department at the FDA that approved all cardiovascular devices and has since developed 6 heart valves. In the US, he is a rock star of heart valve development.

This is a transformational development and can justify the multi bagged that everyone is looking for.

[mikeh30] 21/5/2018 07:24

Let's see what the completed strategic review states. Must be complete now. Who took the 7m shares?